Keyphrases
Randomized Trial
100%
Methicillin-resistant Staphylococcus Aureus
100%
Staphylococcus Aureus Bacteremia
100%
Fosfomycin
100%
Cloxacillin
100%
Treatment Efficacy
36%
Monotherapy
9%
Confidence Interval
9%
Intention-to-treat
9%
Adverse Events
9%
Randomized Clinical Trial
9%
Treatment Failure
9%
Intrinsic Heterogeneity
9%
Interim Analysis
9%
Mortality Event
9%
Persistent Bacteremia
9%
Days of Treatment
9%
Composite Endpoint
9%
Risk Difference
9%
Combination Treatment
9%
Improved Patient Outcomes
9%
Afebrile
9%
Hospitalized Adults
9%
Personalized Approach
9%
Negative Culture
9%
Treatment Allocation
9%
Quick Sequential Organ Failure Assessment (qSOFA)
9%
Pharmacology, Toxicology and Pharmaceutical Science
Staphylococcal Bacteremia
100%
Fosfomycin
100%
Methicillin Susceptible Staphylococcus Aureus
100%
Cloxacillin
100%
Randomized Clinical Trial
9%
Infection
9%
Adverse Event
9%
Monotherapy
9%
Bloodstream Infection
9%
Organ Dysfunction Score
9%
Immunology and Microbiology
Methicillin Susceptible Staphylococcus Aureus
100%
Arm
16%